Options for regulating new psychoactive drugs: a review of recent experiences

Document type
Reuter, Peter
UK Drug Policy Commission
Date of publication
1 May 2011
Substance Misuse
Social welfare
Material type

Download (486KB )

This paper is intended to provide the basis for a discussion of policy options in dealing with new psychoactive substances that show signs of popularity and of harmfulness within a wider project being undertaken by the UK Drug Policy Commission and Demos. The review considers the international context, current approaches to tackling new drugs with a main focus on the USA and Europe, and examines four specific examples of new drugs: BZP, Spice, mephedrone and naphyrone. It also looks at the possible learning from other regulatory frameworks, those for foodstuffs and for alcohol and tobacco.

Related to Substance Misuse

Drug misuse and dependence: UK guidelines on clinical management

Downloadable guidelines on treating people with drug misuse and drug dependence problems

Family drug and alcohol court national unit: independent evaluation: research report

The family drug and alcohol court (FDAC) offers an alternative form of care proceedings for children put at risk of significant…

Fourth addendum to ACMD’s report on synthetic cannabinoids

This addendum recommends revisions to the regulations regarding the scheduling of synthetic cannabinoids. Specifically, they…

More items related to this subject